LIXTE BIOTECHNOLOGY HOLDINGS, INC. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lixte Biotechnology Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Lixte Biotechnology Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$983K, a 4% increase year-over-year.
  • Lixte Biotechnology Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$3.99M, a 30% increase year-over-year.
  • Lixte Biotechnology Holdings, Inc. annual Operating Income (Loss) for 2023 was -$5.09M, a 19.4% increase from 2022.
  • Lixte Biotechnology Holdings, Inc. annual Operating Income (Loss) for 2022 was -$6.31M, a 6.09% increase from 2021.
  • Lixte Biotechnology Holdings, Inc. annual Operating Income (Loss) for 2021 was -$6.72M, a 106% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.